• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

老年人的身体成分及其与心血管代谢危险因素的关系:关注肌少症性肥胖。

Body composition and its association with cardiometabolic risk factors in the elderly: a focus on sarcopenic obesity.

机构信息

Department of Family Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea.

出版信息

Arch Gerontol Geriatr. 2013 Jan-Feb;56(1):270-8. doi: 10.1016/j.archger.2012.09.007. Epub 2012 Oct 15.

DOI:10.1016/j.archger.2012.09.007
PMID:23079031
Abstract

Important changes in body composition with aging are a progressive loss of muscle mass and increase of fat mass. Despite their enormous clinical importance, body composition changes such as sarcopenic obesity in the elderly are under-recognized. This study aimed to examine the relationship of body composition with a wide variety of cardiometabolic risk factors among 2943 subjects (1250 men and 1693 women) aged 60 years or older from Korean National Health Examination and Nutrition Survey (KNHANES). Sarcopenia was defined as an appendicular skeletal muscle mass (ASM) divided by weight (%) of < 1 SD below the sex-specific mean for young adults. Obesity was defined as a body mass index (BMI) ≥ 25 kg/m(2). Body composition was categorized into four non-overlapping groups: the sarcopenic obese, sarcopenic nonobese, nonsarcopenic obese, and nonsarcopenic nonobese groups. A wide variety of cardiometabolic risk factors, including blood pressure (BP), glucose tolerance indices, lipid profiles, inflammatory markers, and vitamin D level, were compared according to body composition group. The prevalence of sarcopenic obesity was 18.4% in men and 25.8% in women. In both sexes, the prevalence of vitamin D deficiency and metabolic syndrome was highly prevalent in the sarcopenic obese group. Serum insulin level, homeostasis model assessment of insulin resistance (HOMA-IR), triglyceride levels, and ferritin levels were the highest in the sarcopenic obese group in both men and women, whereas HDL-cholesterol and 25-hydroxyvitamin D (25(OH)D) levels were the lowest in the sarcopenic obese group. The sarcopenic obese group was more closely associated with insulin resistance, metabolic syndrome, and cardiovascular disease (CVD) risk factors than any other group in this elderly population.

摘要

随着年龄的增长,身体成分会发生重要变化,肌肉量逐渐减少,脂肪量增加。尽管老年人的身体成分变化(如肌少症性肥胖)具有巨大的临床重要性,但这些变化仍未得到充分认识。本研究旨在调查 2943 名 60 岁及以上韩国国民健康与营养调查(KNHANES)参与者的身体成分与各种心血管代谢危险因素之间的关系,其中包括 1250 名男性和 1693 名女性。肌少症定义为四肢骨骼肌质量(ASM)除以年轻人性别特异性平均值的体重(%)低于 1 个标准差。肥胖定义为体重指数(BMI)≥25kg/m2。身体成分分为四个不重叠的组:肌少症性肥胖组、肌少症非肥胖组、非肌少症性肥胖组和非肌少症非肥胖组。根据身体成分组比较了各种心血管代谢危险因素,包括血压(BP)、葡萄糖耐量指数、血脂谱、炎症标志物和维生素 D 水平。男性和女性的肌少症性肥胖患病率分别为 18.4%和 25.8%。在两性中,肌少症性肥胖组维生素 D 缺乏和代谢综合征的患病率均较高。血清胰岛素水平、胰岛素抵抗评估的稳态模型(HOMA-IR)、甘油三酯水平和铁蛋白水平在男性和女性中均为肌少症性肥胖组最高,而高密度脂蛋白胆固醇和 25-羟维生素 D(25(OH)D)水平在肌少症性肥胖组最低。与其他组相比,肌少症性肥胖组与胰岛素抵抗、代谢综合征和心血管疾病(CVD)危险因素更为密切相关。

相似文献

1
Body composition and its association with cardiometabolic risk factors in the elderly: a focus on sarcopenic obesity.老年人的身体成分及其与心血管代谢危险因素的关系:关注肌少症性肥胖。
Arch Gerontol Geriatr. 2013 Jan-Feb;56(1):270-8. doi: 10.1016/j.archger.2012.09.007. Epub 2012 Oct 15.
2
Sarcopenic obesity is more closely associated with knee osteoarthritis than is nonsarcopenic obesity: a cross-sectional study.一项横断面研究表明,相较于非肌肉减少性肥胖,肌肉减少性肥胖与膝关节骨关节炎的关联更为密切。
Arthritis Rheum. 2012 Dec;64(12):3947-54. doi: 10.1002/art.37696.
3
Relationships between sarcopenic obesity and insulin resistance, inflammation, and vitamin D status: the Korean Sarcopenic Obesity Study.肌少症性肥胖与胰岛素抵抗、炎症和维生素 D 状态的关系:韩国肌少症性肥胖研究。
Clin Endocrinol (Oxf). 2013 Apr;78(4):525-32. doi: 10.1111/j.1365-2265.2012.04433.x.
4
Gender-specific association between urinary sodium excretion and body composition: Analysis of the 2008-2010 Korean National Health and Nutrition Examination Surveys.尿钠排泄与身体成分之间的性别特异性关联:对2008 - 2010年韩国国民健康与营养检查调查的分析。
Metabolism. 2015 Jul;64(7):837-44. doi: 10.1016/j.metabol.2015.03.010. Epub 2015 Apr 1.
5
Sarcopenic/obesity and physical capacity in older men and women: data from the Nutrition as a Determinant of Successful Aging (NuAge)-the Quebec longitudinal Study.老年人的肌肉减少性肥胖和身体能力:来自营养决定成功老龄化研究(NuAge)-魁北克纵向研究的数据。
Obesity (Silver Spring). 2009 Nov;17(11):2082-8. doi: 10.1038/oby.2009.109. Epub 2009 Apr 16.
6
Effect of sarcopenia on cardiovascular disease risk factors in obese postmenopausal women.肌肉减少症对肥胖绝经后女性心血管疾病危险因素的影响。
Obesity (Silver Spring). 2006 Dec;14(12):2277-83. doi: 10.1038/oby.2006.267.
7
Relationship between sarcopenic obesity and cardiovascular disease risk as estimated by the Framingham risk score.通过弗明汉风险评分评估的肌少症肥胖与心血管疾病风险之间的关系。
J Korean Med Sci. 2015 Mar;30(3):264-71. doi: 10.3346/jkms.2015.30.3.264. Epub 2015 Feb 16.
8
Prevalence of sarcopenia and sarcopenic obesity in the Korean population based on the Fourth Korean National Health and Nutritional Examination Surveys.基于第四次韩国国家健康和营养检查调查,韩国人群中肌少症和肌少症性肥胖的流行情况。
J Gerontol A Biol Sci Med Sci. 2012 Oct;67(10):1107-13. doi: 10.1093/gerona/gls071. Epub 2012 Mar 19.
9
Gamma-glutamyl transferase is associated with sarcopenia and sarcopenic obesity in community-dwelling older adults: results from the Fifth Korea National Health and Nutrition Examination Survey, 2010-2011.γ-谷氨酰转移酶与社区居住的老年人肌肉减少症和肌肉减少性肥胖有关:2010 - 2011年第五次韩国国家健康与营养检查调查结果
Endocr J. 2015;62(7):585-92. doi: 10.1507/endocrj.EJ15-0119. Epub 2015 May 25.
10
Comparison between several insulin sensitivity indices and metabolic risk factors in overweight and obese postmenopausal women: a MONET study.超重和肥胖绝经后妇女几种胰岛素敏感性指数与代谢危险因素的比较:MONET 研究。
Nutr Metab Cardiovasc Dis. 2010 Mar;20(3):173-9. doi: 10.1016/j.numecd.2009.03.005. Epub 2009 Jun 5.

引用本文的文献

1
Prevention of Sarcopenia.预防肌肉减少症。
Adv Exp Med Biol. 2025;1478:365-405. doi: 10.1007/978-3-031-88361-3_15.
2
Muscle-building interventions improve glucose metabolism in elderly type 2 diabetic patients with sarcopenic obesity.肌肉增强干预措施可改善患有肌少症肥胖的老年2型糖尿病患者的葡萄糖代谢。
Nutr Metab (Lond). 2025 Aug 13;22(1):98. doi: 10.1186/s12986-025-00993-2.
3
Longitudinal changes of body composition during a 3-year follow-up in Taiwan adults with type 2 diabetes.台湾2型糖尿病成年患者3年随访期间身体成分的纵向变化。
BMJ Nutr Prev Health. 2025 Jun 18;8(1):e000995. doi: 10.1136/bmjnph-2024-000995. eCollection 2025.
4
Construction of a prediction model for sarcopenic obesity based on machine learning.基于机器学习构建肌肉减少性肥胖预测模型。
Front Public Health. 2025 Jun 27;13:1576338. doi: 10.3389/fpubh.2025.1576338. eCollection 2025.
5
The Effect of Frailty on Body Composition and Its Impact on the Use of SGLT-2 Inhibitors and GLP-1RA in Older Persons with Diabetes.衰弱对身体成分的影响及其对老年糖尿病患者使用钠-葡萄糖协同转运蛋白2抑制剂和胰高血糖素样肽-1受体激动剂的影响。
Metabolites. 2025 Jun 9;15(6):381. doi: 10.3390/metabo15060381.
6
Association of possible Sarcopenia, Sarcopenia and sarcopenic obesity with multimorbidity among middle-aged and older adults: findings from the China health and retirement longitudinal study.中年及老年人群中潜在肌肉减少症、肌肉减少症和肌肉减少性肥胖与多种疾病的关联:来自中国健康与养老追踪调查的结果
Arch Public Health. 2025 Mar 25;83(1):77. doi: 10.1186/s13690-025-01538-y.
7
The Use of SGLT-2 Inhibitors and GLP-1RA in Frail Older People with Diabetes: A Personalised Approach Is Required.SGLT-2抑制剂和GLP-1受体激动剂在老年体弱糖尿病患者中的应用:需要个性化方法。
Metabolites. 2025 Jan 14;15(1):49. doi: 10.3390/metabo15010049.
8
Sarcopenic Obesity: A Comprehensive Approach for Postmenopausal Women.肌少性肥胖:绝经后女性的综合应对方法
J Menopausal Med. 2024 Dec;30(3):143-151. doi: 10.6118/jmm.24004.
9
Sex-specific associations between total and regional Fat-to-muscle Mass ratio and cardiometabolic risk: findings from the China National Health Survey.性别特异性脂肪-肌肉质量比与心血管代谢风险的关系:来自中国国家健康调查的结果。
Nutr J. 2024 Sep 10;23(1):104. doi: 10.1186/s12937-024-01007-2.
10
Trajectories of cardiovascular ageing - from molecular mechanisms to clinical implementation.心血管衰老的轨迹——从分子机制到临床应用
Cardiovasc Res. 2024 Aug 23. doi: 10.1093/cvr/cvae178.